Live Breaking News & Updates on Prof Tipu Sultan

Stay updated with breaking news from Prof tipu sultan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Pakistan earned $10m from Phase-III clinical trials of Covid-19 vaccine'


July 11, 2021
Pakistan has earned $10 million by conducting first-ever Phase-III clinical trials for the single-dose Chinese Covid-19 vaccine CanSino Bio at five leading public and private health facilities in the country, and now the National Institute of Health (NIH) is going to earn 30 million dollars within a year by co-manufacturing the same vaccine after technology transfer from China, officials said on Saturday.
“Phase-III clinical trials of the CanSino Biologics single-dose Covid-19 were the first-ever such trials conducted in Pakistan and we earned $10 million by conducting these trials at five centres in Karachi, Lahore and Islamabad. Now we are being approached by companies from the UK, Korea and Japan, as well as from China for conducting Phase-III clinical trials of several more vaccines, which can earn us huge revenue and foreign exchange,” said Major General Aamer Ikram, executive director of the National Institute of Health Islamabad, at a health confe ....

United Kingdom , Aamer Ikram , Cansino Bio , Tipu Sultan , Mahmood Haider , Cansino Biologics , Dow University Of Health Sciences , Bahria University , Malir University , National Institute Of Health , Aga Khan University , International Conference , National Institute Of Health Islamabad , National Institute , Major General Aamer Ikram , Health Islamabad , Major General Ikram , Bahria University Medical , Dental College , Dow University , Health Sciences , Prof Tipu Sultan , Karachi Medical , ஒன்றுபட்டது கிஂக்டம் , ஆமேர் இக்கிரம் , கேன்சினோ உயிர் ,